Budesonide Inhaler Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Budesonide Inhaler Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma is not just a public health problem for high income countries, as it occurs in all countries regardless of level of development. Over 80% of asthma deaths occur in low and lower-middle income countries. Asthma is under-diagnosed and under-treated, creating a substantial burden to individuals and families and possibly restricting individuals’ activities for a lifetime.

Market Dynamics

The global demand for budesonide inhaler is expected to witness substantial growth over the forecast period, owing to increasing incidences and prevalence of asthma. According to the Global Asthma Report 2018, asthma causes around 1000 deaths every day and affects as many as 339 million people worldwide.

Furthermore, major players in the market are focused on developing new drug combinations for paediatric use. For instance, in January 2017, AstraZeneca announced that the U.S. FDA approved Symbicort (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of asthma in paediatric patients aged 6 to 12 years. Budesonide/formoterol is already approved in the U.S. to treat asthma in patients 12 years and older and for the maintenance treatment of airflow obstruction in Chronic Obstructive Pulmonary Disease (COPD) in adults.

However, product recalls due to failure to meet regulatory guidelines is expected to hinder the market growth. For instance, in 2014, AstraZeneca’s PULMICORT RESPULES (budesonide inhalation suspension) was recalled by the U.S. FDA as budesonide may be above or below the specification range, which can be harmful for the patients.

Key features of the study:

  • This report provides in-depth analysis of the budesonide inhaler market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global budesonide inhaler market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, Pfizer Inc., Cipla Limited, Lupin Limited, Cosmo Pharmaceuticals, Takeda Pharmaceutical Company Ltd., Manus Aktteva Biopharma LLP, Abbott Laboratories, Lunan Better Pharmaceutical, Novartis International AG (Sandoz), Mylan N.V., Skyepharma, AstraZeneca Plc., Chiesi Farmaceutici S.p.A, Orion Corporation, Santarus Inc., Synmosa Biopharma Corporation, and Shanghai Sine Pharmaceutical Laboratories Co. Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global budesonide inhaler market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for budesonide inhaler market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
  • Global Budesonide Inhaler Market, By Product Type:
  • Inhalants
  • Nebulizer
  • Global Budesonide Inhaler Market, By Dosage:
  • Aerosols
  • Dry Powder
  • Suspension
  • Spray
  • Global Budesonide Inhaler Market, By Strength:
  • 0.25 mg
  • 0.5 mg
  • 1.0 mg
  • Global Budesonide Inhaler Market, By Distribution Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Global Budesonide Inhaler Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Product Type:
  • Inhalants
  • Nebulizer
  • By Dosage:
  • Aerosol
  • Dry Powder
  • Suspension
  • Spray
  • By Strength:
  • 0.25 mg
  • 0.5 mg
  • 1.0 mg
  • By Distributional Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Product Type:
  • Inhalants
  • Nebulizer
  • By Dosage:
  • Aerosol
  • Dry Powder
  • Suspension
  • Spray
  • By Strength:
  • 0.25 mg
  • 0.5 mg
  • 1.0 mg
  • By Distributional Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Product Type:
  • Inhalants
  • Nebulizer
  • By Dosage:
  • Aerosol
  • Dry Powder
  • Suspension
  • Spray
  • By Strength:
  • 0.25 mg
  • 0.5 mg
  • 1.0 mg
  • By Distributional Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Product Type:
  • Inhalants
  • Nebulizer
  • By Dosage:
  • Aerosol
  • Dry Powder
  • Suspension
  • Spray
  • By Strength:
  • 0.25 mg
  • 0.5 mg
  • 1.0 mg
  • By Distributional Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Product Type:
  • Inhalants
  • Nebulizer
  • By Dosage:
  • Aerosol
  • Dry Powder
  • Suspension
  • Spray
  • By Strength:
  • 0.25 mg
  • 0.5 mg
  • 1.0 mg
  • By Distributional Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Africa
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • By Product Type:
  • Inhalants
  • Nebulizer
  • By Dosage:
  • Aerosol
  • Dry Powder
  • Suspension
  • Spray
  • By Strength:
  • 0.25 mg
  • 0.5 mg
  • 1.0 mg
  • By Distributional Channel:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Company Profiles
  • Pfizer Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Cipla Limited
  • Lupin Limited
  • Cosmo Pharmaceuticals
  • Takeda Pharmaceutical Company Ltd.
  • Manus Aktteva Biopharma LLP
  • Abbott Laboratories
  • Lunan Better Pharmaceutical
  • Novartis International AG (Sandoz)
  • Mylan N.V.
  • Skyepharma,
  • AstraZeneca Plc.
  • Chiesi Farmaceutici S.p.A.
  • Orion Corporation
  • Santarus Inc.
  • Synmosa Biopharma Corporation
  • Shanghai Sine Pharmaceutical Laboratories Co. Ltd.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Dosage
Market Snippet, By Strength
Market Snippet, By Distributional Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Landscape
Product Recall
Epidemiology Analysis
Technology Overview
PEST Analysis
Porter’s Five Forces Model
4. Global Budesonide Inhaler Market, By Product Type, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Inhalants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Nebulizers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
5. Global Budesonide Inhaler Market, By Dosage, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Aerosols
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Dry Powder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Suspension
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Spray
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
6. Global Budesonide Inhaler Market, By Strength, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
0.25mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
0.5 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
1.0 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
7. Global Budesonide Inhaler Market, By Distributional Channel, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
8. Global Budesonide Inhaler Market, By Region, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2017 – 2026
Regional Trends
North America
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Dosage, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Strength, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distributional Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Dosage, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Strength, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distributional Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Dosage, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Strength, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distributional Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Dosage, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Strength, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distributional Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Dosage, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Strength, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distributional Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Dosage, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Strength, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distributional Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
9. Competitive Landscape
Company Profiles
Pfizer, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Cipla Limited
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Lupin Limited
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Cosmo Pharmaceuticals
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Takeda Pharmaceutical Company Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Manus Aktteva Biopharma LLP
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Abbott Laboratories
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Lunan Better Pharmaceutical
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Novartis International AG (Sandoz)
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Mylan N.V.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Skyepharma
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
AstraZeneca Plc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Chiesi Farmaceutici S.p.A.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Orion Corporation
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Santarus Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Synmosa Biopharma Corporation
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Shanghai Sine Pharmaceutical Laboratories Co. Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Analyst Views
10. Section
References
Research Methodology
About Us and Sales Contact
*Browse 21 market data tables and 19 figures on “Budesonide Inhaler Market” – Global forecast to 2026”

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook